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Abstract
Objectives: Dysbiosis of the gut microbiome is implicated in numerous human health conditions. Animal studies have
linked microbiome disruption to changes in cognitive functioning, although no study has examined this possibility in
neurologically healthy older adults. Methods: Participants were 43 community-dwelling older adults (50–85 years)
that completed a brief cognitive test battery and provided stool samples for gut microbiome sequencing. Participants
performing≥ 1 SD below normative performance on two or more tests were compared to persons with one or fewer
impaired scores. Results: Mann Whitney U tests revealed different distributions of Bacteroidetes (p = .01), Firmicutes
(p = .02), Proteobacteria (p = .04), and Verrucomicrobia (p = .003) between Intact and Impaired groups. These phyla
were significantly correlated with cognitive test performances, particularly Verrucomicrobia and attention/executive
function measures. Conclusions: The current findings suggest that composition of the gut microbiome is associated with
cognitive test performance in neurologically healthy older adults. Future studies are needed to confirm these findings and
explore possible mechanisms. (JINS, 2017, 23, 700–705)
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INTRODUCTION
The human intestine supports a diverse and active ecosystem
of microorganisms distinct from the human genome, collec-
tively referred to as the gut microbiota (Bäckhed, Ley,
Sonnenburg, Peterson, & Gordon, 2005). All three domains
of cellular life (i.e., archaea, bacteria, and eukarya) can be
found in the microbiota, together outnumbering human cells
in the gut by approximately 10 to 1 (Bäckhed, et al., 2005). In
healthy hosts, this ecosystem contains mostly symbiotic and
commensal organisms that coexist without harm to either the
host or to the microorganisms themselves (Bäckhed, et al.,
2005). In fact, a healthy gut microbiota benefits its host by
supplying essential nutrients and aiding in digestion and
immune functions.
However, the composition of the microbiota is influenced
by many factors, including intestinal motility, pH value, and
bodily secretions, even extending to host lifestyle factors,
such as antibiotic usage, diet, stress, and age (Tilg & Kaser,
2011). While some changes to the composition of the
microbiota and variance across individuals is normative,
dysbiosis of the gut microbiota can become pathogenic.
Dysbiosis can result from host or environmental factors and
has been linked to several disease conditions, including
inflammatory bowel disease, some types of cancer, obesity,
and metabolic disorders (Tilg & Kaser, 2011).
While research on the connection between the gut
microbiome and the brain (i.e., the gut–brain axis) is newly
developing and research in humans is limited, a parallel
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literature demonstrates possible links to both neurocognitive
and psychiatric outcomes (Sarkar et al., 2016). One such
study used a microbiome depletion/transplantation paradigm.
Microbiota isolated from obese C57BL/6 donor mice eating
high fat diets were transplanted to nonobese mice. These
nonobese, diet-naïve mice showed changes in exploratory
and stereotypical behaviors (reflecting increased anxiety), as
well as decrements in learning and memory in response to the
microbiota transplant (Bruce-Keller et al., 2015). While
specific changes were not thoroughly investigated, investi-
gators did find lower levels of Akkermansia muciniphila
(a Verrucomicrobium) and higher levels of Bilophila sp.
(a Proteobacterium) in the microbiota of the obese mice on
high fat diets than their normal weight, normal diet counter-
parts (Bruce-Keller et al., 2015).
Another study examined C57BL/6J mice switched from
a normal chow diet to either a high fat or a high sucrose diet.
After 2 weeks of a high-sucrose diet, mice exhibited problems
in multiple cognitive abilities (e.g., cognitive flexibility,
working and long-term memory), as well as decreases in
Bacteroidales and increases in Lactobacillales and Clos-
tridiales (Magnusson et al., 2015). Those mice on a high
fat diet showed decreased cognitive flexibility, increases
in Erysipelotrichales and Clostridiales, and decreases in
Bacteroidales (Magnusson et al., 2015).
A study using NIH Swiss mice used an antibiotic treatment
from weaning onward to deplete the gut microbiota during
a key developmental period. Compared to control mice, those
with depleted gut microbiota through development demon-
strated reduced anxiety and reduced apparent memory for
familiar objects and social learning as adults (Desbonnet
et al., 2015).
Initial research in humans has also linked composition of
the gut microbiota to cognitive changes. Bajaj et al. (2016)
examined fecal microbiota and cognitive function in patients
with and without liver cirrhosis. In persons with cirrhosis,
poorer cognitive function was correlated with higher
proportions of Lactobacillales and lower proportions of
Enterobacteriaceae and Porphyromonadaceae. Additionally,
individuals with poorer cognitive test scores exhibited
increased inflammation, and initial evidence for an interac-
tion between inflammation, gut dysbiosis, and cognitive
function in healthy individuals without liver-cirrhosis was
also demonstrated (Bajaj et al., 2016). The current study
sought to further explore the possible association between the
composition of the gut microbiome and cognitive function in
a sample of healthy older adults.
METHODS
Participants
A total of 43 older adults were recruited from a community
recreation and wellness center (Table 1). Study participants
were English-speaking and 50–85 years of age. Exclusion
criteria included: (1) history of neurological, developmental,
or severe psychiatric disorder (i.e., conditions known to
independently impact cognitive function); (2) The Mini
Mental State Exam (MMSE) score ≤ 24; (3) antibiotic use in
the past 30 days; (4) history of significant gastrointestinal
surgery; (5) history of alcohol or illicit drug dependence;
or (6) history of severe heart, kidney, or liver problems.
To facilitate analyses with the modest sample, participants
were grouped into Intact versus Impaired groups based on
cognitive test performance. Participants with test scores
falling one or more standard deviations below normative test
performance on two or more tests (i.e., Impaired) were
compared to those with one or fewer impaired test scores (i.e.,
Intact). This approach accounts for the high prevalence of
individuals obtaining a single impaired test score in this age
range (>70%, Palmer, Boone, Lesser, & Wohl, 1998) and
corresponds with the median number of impaired test
performances within the sample (median = 1.0; Intact group
0.60± 0.50 impaired tests vs. Impaired group 4.33± 2.03
impaired tests). Intact (N= 25) and Impaired (N= 18) groups
did not differ on key demographic, medical, or lifestyle
characteristics (including dietary habits) and no covariates
were used for analyses (See Table 1).
Procedures
All procedures were approved by the Kent State University
Institutional Review Board. Participants were recruited from
a local community recreation and wellness center. After
providing written informed consent, participants completed
the neuropsychological test battery, administered by an
examiner and using paper and pencil, in a quiet room. After
testing, participants received the self-report questionnaire
packet and stool sample kit, with instructions to complete
them at home and return by mail. The stool samples were
collected in kits prearranged by Ubiome (www.ubiome.
com). Samples were mailed directly to Ubiome in sterile,
capped tubes containing proprietary buffer. 16S rRNA
amplicon sequencing was done following protocols from the




A brief neuropsychological test battery assessed cognitive
functioning. Measures were chosen for their known sensi-
tivity to cognitive dysfunction in an older adult population
and all raw scores were transformed into t scores using
normative data.
Global cognitive function. MMSE examines global
cognitive functioning by briefly assessing various cognitive
domains. Total scores range from 0 to 30 with lower scores
indicating poorer performances (Folstein, Folstein, &
McHugh, 1975). Low MMSE scores were used as an exclu-
sion criterion and were not used as measures of cognitive
function in analyses.
Gut microbiome and cognitive function 701
Attention/executive function. The Frontal Assessment
Battery (FAB) is a composite measure of executive function
and comprised of six subtests, incorporating aspects of
conceptualization, mental flexibility, inhibitory control, and
sensitivity to interference (Dubois, Slachevsky, Litvan, &
Pillon, 2000). Trail Making Test A (TMT-A) has individuals
draw lines to quickly connect numbered circles in ascending
order and provides a measure of complex visual scanning and
psychomotor speed, while Trail Making Test B (TMT-B) has
individuals alternate connecting numbers and letters (e.g.,
1–A – 2 – B, etc.) and provides a measure of set-shifting
(Dikmen, Heaton, Grant, & Temkin, 1999). The Stroop Color
Word Test (Golden & Freshwater, 2002) requires that indi-
viduals indicate the color ink in which a word is printed,
while ignoring the word itself, which is a different color word
(e.g., “blue” printed in red ink). It is a commonly used
measure of mental flexibility and selective attention.
Memory. The Hopkins Verbal Learning Test-Revised
(HVLT-R; Brandt, 1991) is a test of verbal memory requiring
learning, recall, and recognition of a 12-item word list. The
Rey-Osterrieth Complex Figure Task (RCFT) measures
memory for complex visual information by asking partici-
pants to copy a complicated geometric figure (learning task),
immediately draw the figure again from memory (immediate
recall), and later draw the figure from memory (delayed
recall; Loring, Martin, Meador, & Lee, 1990).
Language. A measure of verbal fluency (Verbal Asso-
ciation Fluency, FAS) asks participants to name as many
words beginning with a specific letter as possible in 60 s
(Lezak, Howieson, Bigler, & Tranel, 2012), and the Animal
Naming task asks participants to list different animals for
60 s (Lezak et al., 2012).
Questionnaires
Self-report questionnaires were used to clarify possible group
differences. A brief Medical History Questionnaire asked
participants to indicate histories of medical conditions, such
as hypertension, type 2 diabetes, sleep apnea, and gastro-
intestinal disorders, among others. The EPIC-Norfolk Food
Frequency Questionnaire (FFQ; Mulligan et al., 2014)
quantifies usual food intake over the past 30 days. The Rapid
Assessment of Physical Activity (RAPA) offers a valid
assessment of physical activity among older adults (Topolski
et al., 2006).
Statistical Analyses
All microbiome data were represented as proportions of
total microbiome and then centered before all analyses.
Due to small sample size and non-normal distributions,
Mann-Whitney U tests were used to compare composition of
the microbiome between Intact and Impaired groups. Spear-
man correlations examined the association between specific
phyla and performance on individual cognitive tests. Mean
imputation was used to confirm group assignment for
a participant with missing test data on a single subtest (Stroop
Color Word Test – Color) using regression analyses from
demographic (e.g., age, education, sex) and remaining
cognitive test scores.
RESULTS
Between-Group Differences in Gut Microbiome
Composition
Mann-Whitney U tests using a 95% confidence interval
revealed a different distribution for Bacteroidetes (p = .01),
Firmicutes (p = .02), Proteobacteria (p = .04), and Verru-
comicrobia (p = .003) for Intact relative to Impaired groups.
Intact persons exhibited a lower proportion of Bacteroidetes
and Proteobacteria and higher proportions of Firmicutes and
Verrucomicrobia than the Impaired group. See Table 1.
Mann-Whitney U tests using a 95% confidence interval also
revealed nonsignificant trends for differences in distributions
for Cyanobacteria (p = .06) and Tenericutes (p = .08).
Correlation between specific phyla and cognitive test
performance
Spearman correlations examined possible associations
between the significant phyla in the above analyses and
specific cognitive tests. Analyses showed several significant
associations, most commonly between Verrucomicrobia and
measures of attention, executive function, and memory.
Specifically, larger proportions of Verrucomicrobia were
significantly correlated with better scores on HVLT-R Total
Learning, TMT-A, TMT-B, SCWT Word, and SCWT Color
(r ranging from 0.37 to 0.39; p< .05). Greater proportions of
Firmicutes were significantly correlated with higher scores
on the CFT Immediate (r = 0.39; p< .05) and Delayed
Recall tasks (r = 0.35; p< .05), while higher proportions of
Bacteroidetes were correlated with poorer performances on
the CFT Immediate (r = − 0.34; p< .05) and Delayed Recall
tasks (r = − 0.33; p< .05). Higher proportions of Proteo-
bacteria were significantly correlated with poorer scores on
HVLT-R Recognition/Discrimination, FAB, and FAS
(r ranging from −0.34 to −0.41; p< .05). See Table 2.
DISCUSSION
The findings from the current study are consistent with past
work highlighting an association between the gut micro-
biome and cognitive function, although findings vary some-
what across studies. Generally, the presently observed
correlations indicate that higher proportions of Firmicutes
and Verrucomicrobia may be in some way beneficial or
protective for cognitive function, while higher proportions of
Bacteroidetes and Proteobacteria may be less beneficial, or
possibly deleterious. Such findings are similar to past work in
a mouse model using a microbiome depletion/transplantation
paradigm, in which proportions of Verrucomicrobium were
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Table 1. Demographic information, test scores, and microbiome distributions of 43 community-dwelling older adults
Cognitive group M (SD) or %
Intact Impaired Test df p-Value
Demographic variables
Age 64.08± 6.49 64.06± 9.37 0.01 41 .99
Sex (% female) 32.0% 33.3% 0.01 11 .93
Years of education 16.12± 1.83 14.56± 3.22 2.02 41 .06
Days per month consuming alcohol 8.24± 10.48 3.33± 6.96 1.72 41 .09
RAPA aerobic 6.32± 1.25 5.67± 1.75 1.43 41 .16
Total kcals consumed daily (g) 1312.65± 336.81 1729.49± 1260.23 1.58 41 .12
Carbohydrates consumed daily (g) 137.48± 42.77 181.74± 154.63 1.37 41 .18
Sugars consumed daily (g) 82.11± 37.17 97.97± 82.93 0.84 41 .40
Fat consumed daily (g) 55.52± 21.43 79.55 ±61.80 1.81 41 .08
Protein consumed daily (g) 66.90± 15.98 79.35± 38.00 1.47 41 .15
Cognitive tests
MMSE 29.28± 0.98 28.00± 1.85 2.95 41 .005**
HVLT-R
Total Learning 51.66± 7.06 43.33± 17.44 2.16 41 .04*
Delay Recall 51.84± 8.01 33.71± 21.08 3.94 41 <.001**
Recognition/Discrimination 52.52± 6.60 42.72± 11.98 4.44 41 .001**
RCFT
Immediate Recall 59.96± 10.58 40.89± 18.22 4.44 41 <.001**
Delay Recall 56.36± 10.11 38.06± 19.15 4.07 41 <.001**
TMT-A 54.46± 10.11 42.50± 11.41 3.10 41 .004**
TMT-B 56.21± 8.63 42.61± 19.91 3.12 41 .003**
SCWT
Word 51.25± 5.00 44.28± 6.28 3.96 41 <.001**
Color 50.92± 5.30 43.89± 6.43 3.88 41 <.001**
Color Word 56.21± 8.63 44.00± 11.10 3.96 41 <.001**
FAB 50.64± 13.48 34.78± 15.51 3.57 41 .001**
FAS 57.44± 10.39 50.83± 13.14 1.84 41 .07
Animal Naming 55.76± 9.52 56.03± 10.60 0.09 41 .93
Medical history
Type 2 diabetes 4.0% 16.7% 1.99 1 .16
Cardiovascular disease 12.0% 5.5% 0.52 1 .47
Hypertension 40.0% 38.8% 2.29 1 .32
Sleep apnea 12.0% 11.1% 0.83 1 .66
Smoked in past week 0.0% 5.5% 1.42 1 .23
Microbiome
Euryarchaeota 1.92 X 10−4± 6.49 X 10−4 2.81 X 10−4± 8.90 X 10−4 177.00 — .79
Actinobacteria 1.03 X 10−2± 1.37 X 10−2 7.17 X 10−3± 1.13 X 10−2 151.00 — .35
Bacteroidetes 2.58 X 10−1± 1.39 X 10−1 3.82 X 10−1± 1.24 X 10−1 95.00 — .01*
Chloflexi 2.37 X 10−6± 1.14 X 10−5 0.00 176.00 — .40
Cyanobacteria 2.91 X 10−3± 5.71 X 10−3 4.59 X 10−5± 1.26 X 10−5 126.00 — .06
Elusimicrobia 2.66 X 10−4± 1.28 X 10−3 0.00 176.00 — .40
Firmicutes 6.48 X 10−1± 1.89 X 10−1 5.38 X 10−1± 1.4 X 10−1 102.00 — .02*
Lentisphaerae 6.07 X 105± 1.35 X 10−4 5.62 X 10−5± 1.87 X 10−4 168.00 — .50
Proteobacteria 3.37 X 10−2± 8.20 X 10−2 6.24 X 10−2± 7.32 X 10−2 113.00 — .04*
Spirochaetes 1.18 X 10−6± 5.67 X 10−6 0 176.00 — .40
Synergistetes 8.53 X 10−5± 3.82 X 10−4 2.17 X 10−5± 7.87 X 10−5 174.00 — .65
TM7 1.29 X 10−5± 2.32 X 10−5 1.47 X 10−6± 3.04 X 10−5 182.00 — .94
Tenericutes 1.14 X 10−3± 2.32 X 10−3 6.20 X 10−4± 1.92 X 10−3 133.00 — .08
Verrucomicrobia 4.49 X 10−2± 8.79 X 10−2 9.25 X 10−3± 2.21 X 10−2 80.00 — .003
*p< 0.05.
**p< 0.01.
RAPA aerobic = Rapid Assessment of Physical Activity Aerobic, MMSE = Mini Mental State Exam, HVLT-R = Hopkins Verbal Learning Test – Revised,
RCFT = Rey-Osterrieth Complex Figure Task, TMT = Trail Making Test, SCWT = Stroop Color Word Test, FAB = Frontal Assessment Battery,
FAS = Verbal Association Fluency
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positively associated and proportions of Proteobacterium
were negatively associated with learning and memory per-
formance (Bruce-Keller et al., 2015). Likewise, previous
work in humans also found negative correlations between
proportion of Proteobacteria and Bacteroidetes with cogni-
tive impairment in persons with severe liver dysfunction
(Bajaj et al., 2011).
In contrast to the present findings, in a study using high fat
or high sugar diets to manipulate the gut microbiota in mouse
models Bacteroidetes were positively correlated and Firmi-
cutes were negatively correlated with cognitive function
(Magnusson et al., 2015). Full interpretation of such findings
is difficult, as the many factors influencing the composition
of the gut microbiome are just beginning to be understood
and very few studies have directly examined its possible link
to neurological function. Similarly, the appropriate level of
analyses of gut–brain relationships is unclear at this time
(e.g., phyla, genera, etc.) and requires clarification through
future work in large samples.
Despite this early stage of the literature, there are several
likely mechanisms that warrant evaluation, although inves-
tigation of these mechanisms was outside the scope of the
current, preliminary study. One such possibility is the known
relationship between gut dysbiosis and greater inflammation
(Sarkar et al., 2016). Chronic inflammation has long been
viewed as a contributor to cognitive decline (Trollor et al.,
2012) and there is some evidence that dysbiosis, rather than a
specific phylum of bacteria, may lead to greater inflammation
(Tilg & Kaser, 2011).
Other possible mechanisms have also been suggested for
the link between the gut microbiome and neurocognitive
outcomes, including communication through the vagus
nerve, production of bacterial metabolites, and enteroendo-
crine signaling (as reviewed by Sherwin, Sandhu, Dinan, &
Cryan, 2016). Each of these pathways has the potential to
influence a wide range of physiological processes within the
brain. Other work shows that the gut microbiota can impact
other known contributors to cognitive outcomes, including
glycemic control (Tilg & Kaser, 2011). Identification and
elucidation of these possible pathways is much needed,
particularly as they may lead to novel intervention targets that
promote neurological health through manipulation of the gut
microbiota.
Findings from this preliminary study are limited in several
important ways. First, the small sample was comprised of
healthy community-dwelling older adults and future studies
should include patient samples to examine a wider range of
cognitive functioning. Second, the present study found a
cross-sectional relationship between the gut microbiome and
cognitive test scores, but does not provide insight to possible
mechanisms or trajectories of such a relationship. Prospective
studies that include pre-/pro-biotic supplementation will shed
light on the relationship between the gut microbiome and
cognitive functioning, as they have been proposed as possible
therapeutics for psychiatric conditions (Sarkar et al., 2016)
and may provide similar benefits for neurological deficits.
Additionally, antibiotics are known to affect the micro-
biome, and the 30-day exclusion criterion used here may not
capture persons on longer or more frequent courses of
antibiotics and may influence the observed findings. Finally,
our preliminary study used self-report measures to assess
dietary habits and physical activity levels, which may
account for the lack of association found between diet and
performance on cognitive testing. Studies that more precisely
measure dietary intake, particularly feeding studies or the use
of a more detailed diet log to log food intake over time, and
physical activity, such as actigraphy, will help clarify the
observed association between the gut microbiome and cog-
nitive function (as dietary habits and physical activity are
primary contributors to gut microbiome composition) and
may assist in disentangling the often inconsistent relation-
ships between these factors and cognitive outcomes.
In brief summary, the present study found an association
between the composition of the gut microbiome and
Table 2. Correlations between microbiota phyla and cognitive test performances.
Bacteroidetes Firmicutes Proteobacteria Verrucomicrobia
HVLT-R Total Learning −0.03 .12 −.29 .39*
HVLT-R Delay Recall −.16 .26 −.22 .23
HVLT-R Recognition/Discrimination −.23 .23 −.41* .22
CFT Immediate Recall −.34* .39* −.14 .02
CFT Delay Recall −.33* .35* −.14 .07
TMT-A −.22 .16 −.06 .37*
TMT-B −.22 .13 .04 .37*
SCWT Word −.19 .06 −.15 .38*
SCWT Color −.27 .21 −.16 .38*
SCWT Color Word −.33 .21 −.13 .29
FAB −.19 .26 −.40* .29
FAS −.17 .11 −.34* .31
Animal Naming −.04 −.02 .15 .13
* p< 0.05.
HVLT-R = Hopkins Verbal Learning Test – Revised, RCFT = Rey-Osterrieth Complex Figure Task, TMT = Trail Making Test,
SCWT = Stroop Color Word Test, FAB = Frontal Assessment Battery, FAS = Verbal Association Fluency
704 L. Manderino et al.
cognitive functioning in a sample of healthy older adults.
Such findings raise the possibility that the gut microbiota is a
potential contributor to neurological outcomes in late life and
future studies may lead to novel intervention targets.
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